{"entity":{"type":"insider","cik":"0001930805","url":"/insider/0001930805","json_url":"/insider/0001930805.json","name":"Wise John Drayton","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":12,"first":"2022-08-12","last":"2025-02-07","span_basis":"filed_date"},"name_variants":[{"name":"Wise John Drayton","source":"filing","n_filings":12,"first_seen":"2022-08-12","last_seen":"2025-02-07"}],"transactions":[{"id":4928589,"accession":"0001628280-25-004460","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-004460","line_url":"/filing/0001628280-25-004460#line-3","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":78.91,"price_display":"78.91","price_state":"stated","total_value":789.1,"total_display":"789.10","shares_owned_after":133015.0,"shares_owned_after_display":"133,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-07","filed_date":"2025-02-07","scope":"insider"},{"id":4928585,"accession":"0001628280-25-004460","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-004460","line_url":"/filing/0001628280-25-004460#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7910.0,"shares_display":"7,910","price_per_share":80.9,"price_display":"80.90","price_state":"stated","total_value":639919.0,"total_display":"639,919.00","shares_owned_after":133025.0,"shares_owned_after_display":"133,025","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-06","filed_date":"2025-02-07","scope":"insider"},{"id":4238533,"accession":"0001628280-25-001204","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001628280-25-001204","line_url":"/filing/0001628280-25-001204#line-6","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":287.0,"shares_display":"287","price_per_share":65.4,"price_display":"65.40","price_state":"stated","total_value":18769.8,"total_display":"18,769.80","shares_owned_after":125562.0,"shares_owned_after_display":"125,562","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-10","filed_date":"2025-01-10","scope":"insider"},{"id":4238529,"accession":"0001628280-25-001204","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001628280-25-001204","line_url":"/filing/0001628280-25-001204#line-5","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":392.0,"shares_display":"392","price_per_share":66.21,"price_display":"66.21","price_state":"stated","total_value":25954.32,"total_display":"25,954.32","shares_owned_after":119192.0,"shares_owned_after_display":"119,192","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-08","filed_date":"2025-01-10","scope":"insider"},{"id":4238521,"accession":"0001628280-25-001204","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-25-001204","line_url":"/filing/0001628280-25-001204#line-3","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":65.98,"price_display":"65.98","price_state":"stated","total_value":659800.0,"total_display":"659,800.00","shares_owned_after":122492.0,"shares_owned_after_display":"122,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider"},{"id":4238517,"accession":"0001628280-25-001204","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-001204","line_url":"/filing/0001628280-25-001204#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2908.0,"shares_display":"2,908","price_per_share":65.87,"price_display":"65.87","price_state":"stated","total_value":191549.96,"total_display":"191,549.96","shares_owned_after":119584.0,"shares_owned_after_display":"119,584","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-07","filed_date":"2025-01-10","scope":"insider"},{"id":2048713,"accession":"0001628280-24-025895","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-24-025895","line_url":"/filing/0001628280-24-025895#line-3","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6250.0,"shares_display":"6,250","price_per_share":50.0,"price_display":"50.00","price_state":"stated","total_value":312500.0,"total_display":"312,500.00","shares_owned_after":121657.0,"shares_owned_after_display":"121,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":2048711,"accession":"0001628280-24-025895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-025895","line_url":"/filing/0001628280-24-025895#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1602.0,"shares_display":"1,602","price_per_share":48.95,"price_display":"48.95","price_state":"stated","total_value":78417.9,"total_display":"78,417.90","shares_owned_after":121657.0,"shares_owned_after_display":"121,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-28","filed_date":"2024-05-30","scope":"insider"},{"id":2097087,"accession":"0001628280-24-023613","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-023613","line_url":"/filing/0001628280-24-023613#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5088.0,"shares_display":"5,088","price_per_share":25.47,"price_display":"25.47","price_state":"stated","total_value":129591.36,"total_display":"129,591.36","shares_owned_after":123259.0,"shares_owned_after_display":"123,259","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-14","filed_date":"2024-05-15","scope":"insider"},{"id":2870130,"accession":"0001628280-24-001166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-001166","line_url":"/filing/0001628280-24-001166#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1861.0,"shares_display":"1,861","price_per_share":28.78,"price_display":"28.78","price_state":"stated","total_value":53559.58,"total_display":"53,559.58","shares_owned_after":113829.0,"shares_owned_after_display":"113,829","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-09","filed_date":"2024-01-11","scope":"insider"},{"id":2048237,"accession":"0001628280-24-000698","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001628280-24-000698","line_url":"/filing/0001628280-24-000698#line-4","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1167.0,"shares_display":"1,167","price_per_share":29.32,"price_display":"29.32","price_state":"stated","total_value":34216.44,"total_display":"34,216.44","shares_owned_after":115690.0,"shares_owned_after_display":"115,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-05","filed_date":"2024-01-05","scope":"insider"},{"id":2048234,"accession":"0001628280-24-000698","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-24-000698","line_url":"/filing/0001628280-24-000698#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Stock Option (right to buy)","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20071.0,"shares_display":"20,071","price_per_share":29.19,"price_display":"29.19","price_state":"stated","total_value":585872.49,"total_display":"585,872.49","shares_owned_after":103984.0,"shares_owned_after_display":"103,984","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-03","filed_date":"2024-01-05","scope":"insider"},{"id":8510304,"accession":"0001628280-23-019941","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-019941","line_url":"/filing/0001628280-23-019941#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3366.0,"shares_display":"3,366","price_per_share":18.95,"price_display":"18.95","price_state":"stated","total_value":63785.7,"total_display":"63,785.70","shares_owned_after":102681.0,"shares_owned_after_display":"102,681","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-25","filed_date":"2023-05-26","scope":"insider"},{"id":8639540,"accession":"0001628280-23-018700","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001628280-23-018700","line_url":"/filing/0001628280-23-018700#line-3","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1913.0,"shares_display":"1,913","price_per_share":18.17,"price_display":"18.17","price_state":"stated","total_value":34759.21,"total_display":"34,759.21","shares_owned_after":106047.0,"shares_owned_after_display":"106,047","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-17","scope":"insider"},{"id":8639537,"accession":"0001628280-23-018700","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-23-018700","line_url":"/filing/0001628280-23-018700#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":381.0,"shares_display":"381","price_per_share":18.44,"price_display":"18.44","price_state":"stated","total_value":7025.64,"total_display":"7,025.64","shares_owned_after":107960.0,"shares_owned_after_display":"107,960","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-16","filed_date":"2023-05-17","scope":"insider"},{"id":8639534,"accession":"0001628280-23-018700","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-018700","line_url":"/filing/0001628280-23-018700#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":593.0,"shares_display":"593","price_per_share":19.29,"price_display":"19.29","price_state":"stated","total_value":11438.97,"total_display":"11,438.97","shares_owned_after":108341.0,"shares_owned_after_display":"108,341","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-15","filed_date":"2023-05-17","scope":"insider"},{"id":8376672,"accession":"0001628280-23-000963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-23-000963","line_url":"/filing/0001628280-23-000963#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":779.0,"shares_display":"779","price_per_share":17.96,"price_display":"17.96","price_state":"stated","total_value":13990.84,"total_display":"13,990.84","shares_owned_after":77272.0,"shares_owned_after_display":"77,272","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-12","scope":"insider"},{"id":8132444,"accession":"0001930805-23-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001930805-23-000001","line_url":"/filing/0001930805-23-000001#line-2","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1160.0,"shares_display":"1,160","price_per_share":19.74,"price_display":"19.74","price_state":"stated","total_value":22898.4,"total_display":"22,898.40","shares_owned_after":70453.0,"shares_owned_after_display":"70,453","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider"},{"id":6336647,"accession":"0001930805-22-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001930805-22-000002","line_url":"/filing/0001930805-22-000002#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7154.0,"shares_display":"7,154","price_per_share":18.84,"price_display":"18.84","price_state":"stated","total_value":134781.36,"total_display":"134,781.36","shares_owned_after":71613.0,"shares_owned_after_display":"71,613","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-22","scope":"insider"},{"id":6942319,"accession":"0001930805-22-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001930805-22-000001","line_url":"/filing/0001930805-22-000001#line-1","is_derivative":false,"issuer_cik":"0001104506","issuer_name":"INSMED Inc","issuer_ticker":"INSM","issuer_name_source":null,"issuer_url":"/issuer/0001104506","owner_cik":"0001930805","owner_name":"Wise John Drayton","owner_url":"/insider/0001930805","role":"Officer (Chief Commercial Officer)","officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":258.0,"shares_display":"258","price_per_share":27.79,"price_display":"27.79","price_state":"stated","total_value":7169.82,"total_display":"7,169.82","shares_owned_after":78767.0,"shares_owned_after_display":"78,767","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-10","filed_date":"2022-08-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001104506","name":"INSMED Inc","url":"/issuer/0001104506","role":"Officer (Chief Commercial Officer)","n_filings":12,"first_seen":"2022-08-12","last_seen":"2025-02-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001930805","retrieved_at":"2026-08-22T04:38:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}